C165H226F2N16O16 — CID 162145122
6-(1-butylpiperidin-4-yl)oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(cyclohexylmethyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;6-(1-cyclohexylpiperidin-4-yl)oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(cyclopropylmethyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(3,3-difluorobutyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;4-ethyl-6-[1-(3-methylbutyl)piperidin-4-yl]oxy-2H-isoquinolin-1-one;4-ethyl-6-[1-(2-methylpropyl)piperidin-4-yl]oxy-2H-isoquinolin-1-one;4-ethyl-6-(1-propylpiperidin-4-yl)oxy-2H-isoquinolin-1-one (PubChem CID 162145122) has the molecular formula C165H226F2N16O16 and a molecular weight of 2727.71 g/mol. Its IUPAC name is 6-(1-butylpiperidin-4-yl)oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(cyclohexylmethyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;6-(1-cyclohexylpiperidin-4-yl)oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(cyclopropylmethyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(3,3-difluorobutyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;4-ethyl-6-[1-(3-methylbutyl)piperidin-4-yl]oxy-2H-isoquinolin-1-one;4-ethyl-6-[1-(2-methylpropyl)piperidin-4-yl]oxy-2H-isoquinolin-1-one;4-ethyl-6-(1-propylpiperidin-4-yl)oxy-2H-isoquinolin-1-one.
| Compound Name | 6-(1-butylpiperidin-4-yl)oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(cyclohexylmethyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;6-(1-cyclohexylpiperidin-4-yl)oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(cyclopropylmethyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(3,3-difluorobutyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;4-ethyl-6-[1-(3-methylbutyl)piperidin-4-yl]oxy-2H-isoquinolin-1-one;4-ethyl-6-[1-(2-methylpropyl)piperidin-4-yl]oxy-2H-isoquinolin-1-one;4-ethyl-6-(1-propylpiperidin-4-yl)oxy-2H-isoquinolin-1-one |
|---|---|
| PubChem CID | 162145122 |
| Molecular Formula | C165H226F2N16O16 |
| Molecular Weight | 2727.71 g/mol |
| Exact Mass | 2725.73 |
| IUPAC Name | 6-(1-butylpiperidin-4-yl)oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(cyclohexylmethyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;6-(1-cyclohexylpiperidin-4-yl)oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(cyclopropylmethyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;6-[1-(3,3-difluorobutyl)piperidin-4-yl]oxy-4-ethyl-2H-isoquinolin-1-one;4-ethyl-6-[1-(3-methylbutyl)piperidin-4-yl]oxy-2H-isoquinolin-1-one;4-ethyl-6-[1-(2-methylpropyl)piperidin-4-yl]oxy-2H-isoquinolin-1-one;4-ethyl-6-(1-propylpiperidin-4-yl)oxy-2H-isoquinolin-1-one |
| SMILES | CCCCN1CCC(Oc2ccc3c(=O)[nH]cc(CC)c3c2)CC1.CCCN1CCC(Oc2ccc3c(=O)[nH]cc(CC)c3c2)CC1.CCc1c[nH]c(=O)c2ccc(OC3CCN(C4CCCCC4)CC3)cc12.CCc1c[nH]c(=O)c2ccc(OC3CCN(CC(C)C)CC3)cc12.CCc1c[nH]c(=O)c2ccc(OC3CCN(CC4CC4)CC3)cc12.CCc1c[nH]c(=O)c2ccc(OC3CCN(CC4CCCCC4)CC3)cc12.CCc1c[nH]c(=O)c2ccc(OC3CCN(CCC(C)(F)F)CC3)cc12.CCc1c[nH]c(=O)c2ccc(OC3CCN(CCC(C)C)CC3)cc12 |
| InChI | InChI=1S/C23H32N2O2.C22H30N2O2.C21H30N2O2.C20H26F2N2O2.C20H26N2O2.2C20H28N2O2.C19H26N2O2/c1-2-18-15-24-23(26)21-9-8-20(14-22(18)21)27-19-10-12-25(13-11-19)16-17-6-4-3-5-7-17;1-2-16-15-23-22(25)20-9-8-19(14-21(16)20)26-18-10-12-24(13-11-18)17-6-4-3-5-7-17;1-4-16-14-22-21(24)19-6-5-18(13-20(16)19)25-17-8-11-23(12-9-17)10-7-15(2)3;1-3-14-13-23-19(25)17-5-4-16(12-18(14)17)26-15-6-9-24(10-7-15)11-8-20(2,21)22;1-2-15-12-21-20(23)18-6-5-17(11-19(15)18)24-16-7-9-22(10-8-16)13-14-3-4-14;1-4-15-12-21-20(23)18-6-5-17(11-19(15)18)24-16-7-9-22(10-8-16)13-14(2)3;1-3-5-10-22-11-8-16(9-12-22)24-17-6-7-18-19(13-17)15(4-2)14-21-20(18)23;1-3-9-21-10-7-15(8-11-21)23-16-5-6-17-18(12-16)14(4-2)13-20-19(17)22/h8-9,14-15,17,19H,2-7,10-13,16H2,1H3,(H,24,26);8-9,14-15,17-18H,2-7,10-13H2,1H3,(H,23,25);5-6,13-15,17H,4,7-12H2,1-3H3,(H,22,24);4-5,12-13,15H,3,6-11H2,1-2H3,(H,23,25);5-6,11-12,14,16H,2-4,7-10,13H2,1H3,(H,21,23);5-6,11-12,14,16H,4,7-10,13H2,1-3H3,(H,21,23);6-7,13-14,16H,3-5,8-12H2,1-2H3,(H,21,23);5-6,12-13,15H,3-4,7-11H2,1-2H3,(H,20,22) |
| InChIKey | ZKLJNIVVJBDQDF-UHFFFAOYSA-N |
| XLogP | 30.75 |
| TPSA | 362.64 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 42 |
| Heavy Atoms | 199 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2727.71 |
| LogP ≤ 5 | 30.75 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 24 |